XIE/2:2026/Jan: Difference between revisions

From yangwa
Line 38: Line 38:
*Analyze reaction products by non‑denaturing electrophoresis using 7.5% native PAGE.
*Analyze reaction products by non‑denaturing electrophoresis using 7.5% native PAGE.
[[File:Ab-Oligo Native 7.5 2026-01-23.jpg|thumb|center|400px]]
[[File:Ab-Oligo Native 7.5 2026-01-23.jpg|thumb|center|400px]]
Conclusion :Nativepage is not a good chose
Conclusion :Nativepage is not a good chose antibody conjugation


==1.21==
==1.21==
===Native-page===
===Native-page===
Samples(1.20 antibody with oligo) and controls were analyzed by native polyacrylamide gel electrophoresis (PAGE) using a 3–5% stacking gel and a 12.5% resolving gel.
Samples(1.20 antibody with oligo) and controls were analyzed by native polyacrylamide gel electrophoresis (PAGE) using a 3–5% stacking gel and a 12.5% resolving gel.

Revision as of 08:04, 26 January 2026

1.13

Synthesis of Anti-Oligo

抗体还原

  • 取2 ul(1mM) TCEP,用 PBS(7.4) 稀释至 20 ul(100uM),取 5 ul稀释后的 TCEP ,加入 85 ul PBS(7.40),涡旋混匀---TCEP溶液pH过低提前中和
  • 取2 ul(50uM)抗体,用 PBS(pH 7.4)稀释至 10 ul(10uM),将 TECP 的 PBS 缓冲液加入其中,37℃ 孵育 2 h.
  • 取1 ul(50uM)抗体,用 PBS(pH7.4)稀释至 8 ul,作为 C 组

偶联

  • 将孵育好的溶液用 PBS(6.5) 洗涤4次(10000g 3.5min),均分样品(A.B)----buffer pH 6.5避免后续加入的Mal被水解(碱性易水解)
  • A(共混组):向 A 中加入 5 ul(100uM) 的 Mal-PEg-DBCO 和 1 ul(1mM) Azide-ssDNA,室温避光孵育 4 h.
  • B(依次组):1)向 B 中加入 5 ul(100uM) 的 Mal-PEg-DBCO,室温避光孵育 2 h. 2)孵育结束后,向其加入1 ul(1mM) Azide-ssDNA,室温避光孵育 2 h.

验证

  • 强还原断开轻重链:向A、B、C中加入对应量的蛋白 loudingbuffer ,再各加入1 ulβ-巯基乙醇,100℃煮 10m in
  • 10% SDS-Page.

1.19

incubation

  • DNA samples were stratified by thiolation status into two primary groups: thiolated DNA (bearing a thiol modification) and non-thiolated DNA (without thiol modification). Within each primary group, samples were further subdivided by phosphate-buffered saline (PBS) pH, yielding subgroups at pH 5.5, 6.5, 6.7, 6.8, 7.0, 7.5, and 8.5. PBS solutions were prepared and adjusted to the target pH and verified with a calibrated pH meter at room temperature.
S1 (100 μM) S2 (100 μM) TFO (100 μM) Buffer
2 μl 2 μl 2 μl 194 μl

FRET

  • Method:Samples were measured in Cy3 and Cy5 channels using appropriate excitation/emission filters under constant instrument settings.

1.20

Antibody reduction

  1. Dilute 2 µL of antibody stock with 1× PBS to 10 µL (10 µM).
  2. Prepare a TCEP working solution by diluting 1.5 µL of 100 µM TCEP with 1× PBS to 90 µL.
  3. Mix the 10 µL antibody with 90 µL TCEP working solution and incubate at 37°C for 2.5 h (final antibody ≈1 µM; TCEP ≈1.5 molar equivalents).
  4. Purify the reduced antibody by three rounds of buffer exchange into 1× PBS.

Antibody functionalization with DBCO

  • Add 5 µL of Mal‑PEG4‑DBCO (100 µM) to the purified, reduced antibody and incubate at 37°C for 2 h (5 eq).

Antibody conjugation to oligo

  • Add 5 µL of Azide‑Oligo (100 µM) to the DBCO‑modified antibody and incubate at 37°C for 2 h to complete the strain‑promoted azide‑alkyne cycloaddition (SPAAC) coupling (5 eq).

Native-page

  • Analyze reaction products by non‑denaturing electrophoresis using 7.5% native PAGE.

Conclusion :Nativepage is not a good chose antibody conjugation

1.21

Native-page

Samples(1.20 antibody with oligo) and controls were analyzed by native polyacrylamide gel electrophoresis (PAGE) using a 3–5% stacking gel and a 12.5% resolving gel.